299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

8 trials found

diseases per page:

Showing 1 to 8 of 8 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2000031817	2020-04-30	2020-04-11	Evaluation and comparison of quality of life between acetylcysteinetablets and placebo in patients w ...	A Randomized, Double-Blinded, Placebo-Controlled, Multiple-Center Clinical Trial to Compare the Qual ...	bronchiectasia	experimental group:Acetylcysteine;control group:placebo;	West China Hospital, Sichuan University	NULL	Pending	18		Both	experimental group:79;control group:40;	Phase 4	China
2	EUCTR2016-000354-35-DK (EUCTR)	12/05/2016	10/02/2016	High dose antioxidant treatment of patients with cystic fibrosis evaluated by measuring desmosine/is ...	High dose antioxidant treatment of patients with cystic fibrosis evaluated by measuring desmosine/is ...	cystic fibrosis MedDRA version: 19.0;Level: LLT;Classification code 10068288;Term: Cystic fibrosis p ...	Trade Name: Mucolysin INN or Proposed INN: ACETYLCYSTEINE SODIUM Trade Name: AAC Hexal INN or Proposed I ...	Aarhus University Hospital	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Denmark
3	EUCTR2013-005481-19-DK (EUCTR)	27/05/2014	27/05/2014	High Dose Antioxidant Treatment for Patients with Cystic Fibrosis	High Dose Antioxidant Treatment for Patients with Cystic Fibrosis	Cystic Fibrosis MedDRA version: 17.0;Level: LLT;Classification code 10068288;Term: Cystic fibrosis p ...	Trade Name: Mucolysin INN or Proposed INN: ACETYLCYSTEINE Other descriptive name: ACETYLCYSTEINE Trade ...	Aarhus University Hospital	NULL	Not Recruiting			Female: yes Male: yes		Phase 2	Denmark
4	NCT02088216 (ClinicalTrials.gov)	April 1, 2014	5/3/2014	Effect of Long-term, High-dose N-acetylcysteine on Exacerbations of Bronchiectaisis	Effect of N-acetylcysteine on Exacerbations of Bronchiectasis (BENE): a Randomized Controlled Trial	Non-Cystic Fibrosis Bronchiectasis	Drug: N-acetylcysteine;Other: On-demand treatment	Qilu Hospital of Shandong University	NULL	Completed	18 Years	80 Years	All	161	N/A	China
5	EUCTR2007-001401-15-DK (EUCTR)	21/05/2010	14/04/2010	Treatment of patients with cystic fibrosis with N-acetylcysteine	Treatment of patients with cystic fibrosis with N-acetylcysteine	Patients with cystic fibrosis and chronic Pseudomonas lung infection MedDRA version: 12.1;Level: LLT ...	Trade Name: ACC600Tabs Product Name: N-acetylcystein Product Code: R05C B01 INN or Proposed INN: ACETYL ...	Rigshospitalet	NULL	Not Recruiting			Female: yes Male: yes		Phase 4	Denmark
6	NCT00996424 (ClinicalTrials.gov)	January 2010	15/10/2009	The Effect of Inhaled N-AcetylcysteineCompared to Normal Saline on Sputum Rheology and Lung Function ...	The Effect of Inhaled N-AcetylcysteineCompared to Normal Saline on Sputum Rheology and Lung Function ...	Cystic Fibrosis	Drug: Acetylcysteine;Drug: normal saline	University Hospital, Ghent	BVSM	Terminated	6 Years	64 Years	Both	19	Phase 4	Belgium
7	EUCTR2008-008317-20-BE (EUCTR)	13/11/2009	21/09/2009	The effect of inhaled N-Acetylcysteinecompared to normal saline on sputum rheology and lung function ...	The effect of inhaled N-Acetylcysteinecompared to normal saline on sputum rheology and lung function ...	Cystic Fibrosis MedDRA version: 12.0;Level: LLT;Classification code 10011762;Term: Cystic fibrosis	Trade Name: Lysomucil 10 % Product Name: N-acetylcysteine INN or Proposed INN: Acetylcysteine	University Hospital Ghent	NULL	Not Recruiting			Female: yes Male: yes			Belgium
8	NCT00809094 (ClinicalTrials.gov)	November 2008	15/12/2008	NAC Phase IIB: A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The ...	A Multi-Center, Phase IIB, Randomized, Placebo-controlled, Double-Blind Study Of The Effects Of N-Ac ...	Cystic Fibrosis	Drug: N-acetylcysteine (NAC);Drug: Placebo	Stanford University	Cystic Fibrosis Foundation Therapeutics	Completed	7 Years	N/A	All	70	Phase 2	United States

First Previous1Next Last